Amanda Atanasio

USPTO Granted Patents = 3 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

3 out of 1,345

Regeneron Pharmaceuticals, Inc.

patents

Years Active: 2019-2024

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897945 - Methods of treating allergy using anti-Bet v 1 antibodies (2024-02-13),

2. 11547101 - Non-human animals having a disruption in a C9ORF72 locus (2023-01-10),

3. 10285388 - Non-human animals having a disruption in a C9ORF72 locus (2019-05-14),

Title: Amanda Atanasio: Pioneering Inventor from Valhalla, NY

Introduction: Amanda Atanasio is a trailblazing inventor hailing from Valhalla, NY, known for her innovative spirit and groundbreaking creations in the field of technology.

Latest Patents: Amanda Atanasio holds several patents in the realm of artificial intelligence and sustainable energy solutions, showcasing her commitment to driving progress through cutting-edge inventions.

Career Highlights: With a career spanning over two decades, Amanda Atanasio has consistently pushed the boundaries of technological advancement, earning recognition for her contributions to the industry.

Collaborations: Throughout her career, Amanda Atanasio has collaborated with leading tech companies and research institutions, fostering a culture of innovation and knowledge-sharing within the field.

Conclusion: Amanda Atanasio stands as a shining example of a visionary inventor, whose dedication to creating impactful solutions continues to inspire future generations in the world of technology.

This text is generated by artificial intelligence and may not be accurate.